Julian W Woo
Examiner (ID: 14928, Phone: (571)272-4707 , Office: P/3731 )
Most Active Art Unit | 3771 |
Art Unit(s) | 3773, 3771, 3731, 3309 |
Total Applications | 2499 |
Issued Applications | 1786 |
Pending Applications | 354 |
Abandoned Applications | 359 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5085008
[patent_doc_number] => 20070275059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Flashmelt oral dosage formulation'
[patent_app_type] => utility
[patent_app_number] => 10/979556
[patent_app_country] => US
[patent_app_date] => 2004-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12980
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10979556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/979556 | Flashmelt oral dosage formulation | Nov 1, 2004 | Abandoned |
Array
(
[id] => 5810702
[patent_doc_number] => 20060081810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Pool chemical tablet'
[patent_app_type] => utility
[patent_app_number] => 10/967985
[patent_app_country] => US
[patent_app_date] => 2004-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4253
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20060081810.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967985 | Pool chemical tablet | Oct 18, 2004 | Issued |
Array
(
[id] => 6938612
[patent_doc_number] => 20050112175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Drug delivery device'
[patent_app_type] => utility
[patent_app_number] => 10/957910
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5959
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112175.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957910 | Drug delivery device | Oct 3, 2004 | Abandoned |
Array
(
[id] => 7116290
[patent_doc_number] => 20050069591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Injectable, oral, or topical sustained release pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 10/950856
[patent_app_country] => US
[patent_app_date] => 2004-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12084
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069591.pdf
[firstpage_image] =>[orig_patent_app_number] => 10950856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/950856 | Injectable, oral, or topical sustained release pharmaceutical formulations | Sep 26, 2004 | Abandoned |
Array
(
[id] => 7116279
[patent_doc_number] => 20050069580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Compositions containing both sedative and non-sedative antihistamines and sleep aids'
[patent_app_type] => utility
[patent_app_number] => 10/943311
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7554
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069580.pdf
[firstpage_image] =>[orig_patent_app_number] => 10943311
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/943311 | Compositions containing both sedative and non-sedative antihistamines and sleep aids | Sep 16, 2004 | Issued |
Array
(
[id] => 5608089
[patent_doc_number] => 20060269605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances'
[patent_app_type] => utility
[patent_app_number] => 10/572963
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9070
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269605.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572963
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572963 | Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances | Sep 14, 2004 | Abandoned |
Array
(
[id] => 4531391
[patent_doc_number] => 07871644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Pharmaceutical composition for oral use with improved absorption'
[patent_app_type] => utility
[patent_app_number] => 10/949114
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 19150
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/871/07871644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10949114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/949114 | Pharmaceutical composition for oral use with improved absorption | Sep 9, 2004 | Issued |
Array
(
[id] => 5710064
[patent_doc_number] => 20060051409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Bezonatate liquid hard capsule dosage form'
[patent_app_type] => utility
[patent_app_number] => 10/936378
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 688
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10936378
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/936378 | Bezonatate liquid hard capsule dosage form | Sep 7, 2004 | Abandoned |
Array
(
[id] => 7156552
[patent_doc_number] => 20050026981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Stable oral solid drug composition'
[patent_app_type] => utility
[patent_app_number] => 10/928464
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8382
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026981.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928464
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928464 | Stable oral solid drug composition | Aug 26, 2004 | Issued |
Array
(
[id] => 7176383
[patent_doc_number] => 20050123583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Medical use of reuterin'
[patent_app_type] => utility
[patent_app_number] => 10/924538
[patent_app_country] => US
[patent_app_date] => 2004-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6960
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123583.pdf
[firstpage_image] =>[orig_patent_app_number] => 10924538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/924538 | Medical use of reuterin | Aug 23, 2004 | Abandoned |
Array
(
[id] => 840175
[patent_doc_number] => 07390503
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-06-24
[patent_title] => 'Ondansetron orally disintegrating tablets'
[patent_app_type] => utility
[patent_app_number] => 10/923021
[patent_app_country] => US
[patent_app_date] => 2004-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8320
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/390/07390503.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923021 | Ondansetron orally disintegrating tablets | Aug 22, 2004 | Issued |
Array
(
[id] => 668191
[patent_doc_number] => 07094429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-22
[patent_title] => 'Process for preparing tannate liquid and semi-solid dosage forms'
[patent_app_type] => utility
[patent_app_number] => 10/921438
[patent_app_country] => US
[patent_app_date] => 2004-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4491
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094429.pdf
[firstpage_image] =>[orig_patent_app_number] => 10921438
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/921438 | Process for preparing tannate liquid and semi-solid dosage forms | Aug 18, 2004 | Issued |
Array
(
[id] => 7025004
[patent_doc_number] => 20050019398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Flashmelt oral dosage formulation'
[patent_app_type] => utility
[patent_app_number] => 10/920851
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12999
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019398.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920851
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920851 | Flashmelt oral dosage formulation | Aug 17, 2004 | Abandoned |
Array
(
[id] => 5820027
[patent_doc_number] => 20060024340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Encapsulated fluorescent whitening compositions for improved surface appearance'
[patent_app_type] => utility
[patent_app_number] => 10/903642
[patent_app_country] => US
[patent_app_date] => 2004-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8814
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10903642
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/903642 | Encapsulated fluorescent whitening compositions for improved surface appearance | Jul 29, 2004 | Abandoned |
Array
(
[id] => 4652277
[patent_doc_number] => 20080039533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Bioactive Compositions Comprising Triazines'
[patent_app_type] => utility
[patent_app_number] => 10/595050
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5258
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595050
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595050 | Bioactive Compositions Comprising Triazines | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7329986
[patent_doc_number] => 20040254176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Combination of an ace inhibitor, a calcium channel blocker and a diuretic'
[patent_app_type] => new
[patent_app_number] => 10/466198
[patent_app_country] => US
[patent_app_date] => 2004-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7694
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254176.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466198
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466198 | Combination of an ace inhibitor, a calcium channel blocker and a diuretic | Jul 26, 2004 | Abandoned |
Array
(
[id] => 623228
[patent_doc_number] => 07138142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-21
[patent_title] => 'Process for producing granules containing branched amino acids'
[patent_app_type] => utility
[patent_app_number] => 10/897000
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2559
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138142.pdf
[firstpage_image] =>[orig_patent_app_number] => 10897000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/897000 | Process for producing granules containing branched amino acids | Jul 22, 2004 | Issued |
Array
(
[id] => 875450
[patent_doc_number] => 07357945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/891561
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3605
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/357/07357945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10891561
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891561 | Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof | Jul 13, 2004 | Issued |
Array
(
[id] => 5834286
[patent_doc_number] => 20060246116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Formula and method for the delivery of medications to animals'
[patent_app_type] => utility
[patent_app_number] => 10/565095
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4806
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246116.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565095
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565095 | Formula and method for the delivery of medications to animals | Jul 13, 2004 | Abandoned |
Array
(
[id] => 7206454
[patent_doc_number] => 20050043272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Compositions and methods for hydrophobic drug delivery'
[patent_app_type] => utility
[patent_app_number] => 10/889555
[patent_app_country] => US
[patent_app_date] => 2004-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6671
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043272.pdf
[firstpage_image] =>[orig_patent_app_number] => 10889555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/889555 | Compositions and methods for hydrophobic drug delivery | Jul 11, 2004 | Abandoned |